Researcher.Life Logo

Journal of Immunotherapy and Precision Oncology : Impact Factor & More

eISSN: 2590-017XpISSN: 2666-2345
JournalOpen Access

Key Metrics

CiteScore
1.8
H-Index
7
SJR
Q3Oncology
SNIP
0.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Immunotherapy and Precision Oncology

Journal of Immunotherapy and Precision Oncology Journal Specifications

Overview
Publisher Innovative Healthcare Institute
Language English
Article Processing ChargesUSD 2400
Publication Time24
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 24
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND, Public domain
OA statementVisit website
View less

Planning to publish in Journal of Immunotherapy and Precision Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Immunotherapy and Precision Oncology

Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
  • 1 Nov 2025
  • Journal of Immunotherapy and Precision Oncology
Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study
  • 1 Nov 2025
  • Journal of Immunotherapy and Precision Oncology
Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service
  • 20 Oct 2025
  • Journal of Immunotherapy and Precision Oncology
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
  • 6 Oct 2025
  • Journal of Immunotherapy and Precision Oncology
Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion
  • 26 Aug 2025
  • Journal of Immunotherapy and Precision Oncology
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment
  • 25 Aug 2025
  • Journal of Immunotherapy and Precision Oncology
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
  • 1 Nov 2025
  • Journal of Immunotherapy and Precision Oncology
Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study
  • 1 Nov 2025
  • Journal of Immunotherapy and Precision Oncology
Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service
  • 20 Oct 2025
  • Journal of Immunotherapy and Precision Oncology
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
  • 6 Oct 2025
  • Journal of Immunotherapy and Precision Oncology
Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion
  • 26 Aug 2025
  • Journal of Immunotherapy and Precision Oncology
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment
  • 25 Aug 2025
  • Journal of Immunotherapy and Precision Oncology

FAQs on Journal of Immunotherapy and Precision Oncology